ReviewMarine drugs2022

Preclinical Development of Seriniquinones as Selective Dermcidin Modulators for the Treatment of Melanoma.

Amanda S Hirata et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.